This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. (REGN) sank 0.31% to $657.15 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.58% to 3,900.79 and Dow Jones Industrial Average falling 0.75% to 31,253.13. This was the stock's second consecutive day of losses. Regeneron Pharmaceuticals Inc. closed $90.27 short of its 52-week high ($747.42), which the company achieved on April 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) fell 0.89% to $173.94, Novartis AG ADR (NOVN.EB) rose 1.11% to $88.65, and Amgen Inc. (AMGN) rose 0.33% to $244.77. Trading volume (607,718) remained 58,673 below its 50-day average volume of 666,391.
Data source: Dow Jones Market Data, FactSet. Data compiled May 19, 2022.
(END) Dow Jones Newswires
May 19, 2022 17:18 ET (21:18 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.